| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  United Ventures We support visionary entrepreneurs to reinvent industries through technology. At United Ventures we look for daring entrepreneurs willing to develop innovative products and technologies, who acknowledge the challenges and risks of our times and still crave to come out on top in business. As entrepreneurs ourselves, our mission is to spot winners and drive them to achieve success and worldwide recognition through our mentorship, financial and business development support. With a long-standing track record of both start-up and scale-up technological companies, we can boast the industry expertise, mentorship and business networking that it takes to create a success story. Thanks … Type: | 23 | 3 | 14 | 56 |
 |  UKTN The home of the UK tech ecosystem. About the tech industry, for the tech industry, UKTN is the ultimate resource for the latest UK tech news, views, information, data and events. Formerly Tech City News, UKTN is the new name and destination for UK tech. Not only do we provide you with the latest news on the UK tech space – from recent investments to changes in policy – our close relationships with industry leaders and game changers gives us the edge in publishing exclusive interviews with inspiring tech pioneers and producing events that bring the industry together and celebrate … Type: | 123 | 35 | 96 | 9 |
 | Triple Ring Technologies Accelerating the pace of innovation. Triple Ring accelerates the pace of innovation, so you can drive growth, start new businesses, launch breakthrough products, overcome hard problems, improve health, and change lives. We are a healthcare-focused co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. Our services span 3 key business lines: Corporate venture building, Technology and product-development services, and Technology translation for government programs. Founded in 2005, Triple Ring has an unparalleled track record supporting clients from startups to many of the world’s largest MedTech and Life Sciences companies. Advanced Research & Development - applied to … Type: | 4 | 0 | 4 | 101 |
 | Tenpoint Therapeutics Ltd Vision-restoring engineered cell-based therapeutics & in vivo reprogramming. Tenpoint Therapeutics is a vision-restoring engineered cell-based therapeutics company. We are embracing a new opportunity to fundamentally reshape the future for people with ocular diseases. We have an ambitious goal with global impact. Type: | 2 | 2 | 0 | 25 |
 | Tech.eu Tech.eu is the premier online publication dedicated to the growing European technology ecosystem(s). Tech.eu is the premier online publication dedicated to the growing European technology ecosystem(s). We deliver a range of editorial products with a clear focus on curated news, actionable information and educational interviews with movers and shakers from across Europe, combined with insightful market intelligence reports based on our proprietary database, events, a jobs platform and a variety of other services. Type: | 162 | 57 | 113 | 16 |
 | StartupItalia Unstoppable Women, 14 ottobre a Milano #SIOS24 Winter, 17/12 a Milano We are now ready to take the next step to create a launchpad with significant impact on the creation of new startups in Italy. Platform with data from startups, innovative companies, investors and skilled people. Educational platform to support mindset building and training for a future generation of entrepreneurs with clear vertical specializations. Services and support for a new generation of startups with appropriate growth models Flexible space to bring together the ecosystem and support flexible expansions for startups and Corporates/SMEs. "The largest Italian community targeting founders, investors, developers … Tags: H2020 Type: | 66 | 20 | 43 | 92 |
 | Intuitive Ventures Accelerating the future of minimally invasive care. Intuitive Ventures is the venture capital arm of Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif. Through its inaugural $100 million fund, Intuitive Ventures invests in and is advancing the digital, device, therapeutic and diagnostic ecosystems of minimally invasive care and beyond, fostering a disciplined and sustainable investment platform that will offer strategic and financial returns for the long term. Building on Intuitive's entrepreneurial beginnings as a medtech and healthcare success story in Silicon Valley, and as a digitally native company, Intuitive Ventures is well-positioned to identify and support early-stage innovators meeting that challenge. … Type: | 6 | 1 | 5 | 7 |
 | Speedinvest Game-changing support for early-stage tech founders from our focused investment teams and in-house operational experts. Speedinvest is one of Europe’s most active early-stage investors with more than €1 billion AuM and 30+ investors based in Berlin, London, Munich, Paris, and Vienna. Founder success is our top priority, so we don’t just send some money and "check-in" at board meetings. Our mission is to empower you with game-changing support through every stage of your journey. Our focused investment teams know your industry inside and out. Their proven experience, know-how, and deep networks are yours from day one. You also have full … Type: | 142 | 54 | 85 | 138 |
 | Ship2B Ventures Investing for a Better World We are a venture capital firm that invests in the best impact startups. Inversión, Inversión de Impacto, Inversión en startups, Inversión en salud, Inversión en medio ambiente, Inversión en educación, Impact Investment, Health, HealthCare, Climate Change, Sustainability, Education, Venture Capital, Private Equity, and Fondo de inversión Type: | 21 | 5 | 9 | 21 |
 | National Energy Technology Laboratory Discovering energy for the future The National Energy Technology Laboratory (NETL) is a U.S. Department of Energy national laboratory that drives innovation and delivers technological solutions for an environmentally sustainable and prosperous energy future. By leveraging its world-class talent and research facilities, NETL is ensuring affordable, abundant and reliable energy that drives a robust economy and national security, while developing technologies to manage carbon across the full life cycle, enabling environmental sustainability for all Americans. Our project portfolio includes research and innovation conducted through partnerships, cooperative research and development agreements, financial assistance, and contractual arrangements with universities and the private … Type: | 7 | 2 | 5 | 467 |
 | Polaris Partners Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators. Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies. Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference. Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better. Type: | 25 | 2 | 14 | 72 |
 | Pharma Intelligence, now Citeline We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our posts moving forward We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our new posts moving forward as we transition! From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market. The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on … Type: | 23 | 9 | 15 | 170 |
 | Pharmaceutiques [Automatic translation follows] The reference information of the pharmaceutical sector Since 1992, the economic, political and regulatory news of the players of the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Reports of major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files Type: | 61 | 13 | 56 | 56 |
 | MedTech in France [Automatic translation follows] We are the French medical technology companies, we innovate every day for patients! Created in 2013, MedTech in France currently brings together more than 40 French companies in the MedTech sector from e-health and telemedicine to optical technologies, surgical robotics, and medical imaging. The Association develops concrete solutions to promote market access, innovations, and showcase French excellence in medical technologies. It has also set itself the mission of developing French champions internationally. MedTech in France has set itself a triple ambition: > provide medical solutions for patients and healthcare workers > provide economic and organizational benefits for … Type: | 30 | 5 | 27 | 7 |
 | Asceneuron SA Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & … Type: | 3 | 2 | 2 | 20 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s leading predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 5 | 0 | 5 | 101 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 5 | 3 | 4 | 50 |
 | Closed Loop Medicine Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed … Type: | 10 | 1 | 5 | 54 |
 | Memorial Sloan Kettering Cancer Center The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around … Type: | 28 | 10 | 13 | 18,749 |
 | MeetFounders Connecting Startups to Leading Experts in Venture Capital MeetFounders builds connections between startups and venture investors. We organize in-person and virtual conferences around the world with top experts in the startup and venture investment world, bringing these thought leaders together in action-packed events! Networking, investment opportunities, pitches from startups, and killer talks from VC and Angel Investors are just a few of the benefits from our events. Hope to see you there! venture capital, angel investment, startups, and conferences Type: | 7 | 1 | 4 | 6 |
 | Medicines Discovery Catapult Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to expertise, technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, drug research, and Neuroscience Type: | 14 | 4 | 11 | 194 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 50 | 7 | 40 | 15 |
 | FUSACQ [Automatic translation follows] FUSACQ is a marketplace dedicated to mergers and acquisitions experts, investment funds and private investors, corporate and individual buyers, and business leaders wishing to sell their company. 1 company is sold every day thanks to the portal (https://www.fusacq.com) which offers: SERVICES TO PROMOTE TAKEOVER-TRANSMISSION OPERATIONS - 2500 advertisements of companies for sale or looking for acquisition - 2000 investment fund participations - 450 CVs of individual buyers - 600 experts involved in all stages of an operation - training in business takeovers and external growth - a company valuation database ALL THE NEWS ON MERGERS, ACQUISITIONS AND … Type: | 113 | 9 | 106 | 12 |
 | The Drawdown Connecting an exclusive community of operational leaders in the private capital fund industry. As the private capital fund industry moves into a new phase of maturity and institutionalisation, the pressure and complexity faced by operational professionals is increasing exponentially. ‘The Drawdown’ offers exclusive access to an expert and supportive network where connections, valuable insight and best practice are shared, including The Drawdown Awards, Summer and Winter Operational Leaders’ Summits as well as focused invitation only events. We are empowering our members to succeed in this complex environment and to play an instrumental role in shaping the future of our industry. … Type: | 10 | 3 | 9 | 4 |
 | Pi-Cardia Leading the way for leaflet modification Pi-Cardia is a medical device company and market leader in the development of a broad portfolio of leaflet modification solutions for treating heart valves. The company has years of knowledge and expertise accumulated in degenerated valves, including calcification patterns, mode of valve failure, and impact of various methods of leaflet modification. ShortCutTM is designed to provide a safe, simple, and effective way to split leaflets of a pre-existing valve to enable TAVR in patients at risk for coronary obstruction and may assist in preserving coronary access. Medical Device, Aortic Stenosis, Precautions Catheter-System, Cardiovascular, leaflet … Type: | 2 | 1 | 1 | 58 |
 | Boursorama [Automatic translation follows] The bank we want to recommend. Launched in 1998, Boursorama is a pioneering and leading player in its core activities: online banking and economic and financial information. With a development centered around new customer expectations, simplicity and efficiency, but also security and reduced fees, Boursorama strengthens its position as a major banking player in Europe every year. - Complementary and attractive professions in complete synergy - An ability to stay ahead of consumer behavior, in a logic of quality of service and customer satisfaction - A socially committed and environmentally responsible employer, certified B Corp Banking, Markets, … Type: | 156 | 83 | 68 | 1,094 |
 | BIOTECHFINANCES [Automatic translation follows] 1st weekly newsletter of specialized information, biotech, medtech, e-health, finance published by Jacques Bernard Taste PRESENTATION The weekly letter Biotech Finances approaches from an economic and financial angle all the questions related to the development of the biotechnology sector and more broadly of life sciences. Our target readership is mainly composed of biotechnology companies oriented towards health and the development of new therapies and new treatments for diseases, pharmaceutical companies (big pharma and other laboratories), investors, business angels, investment funds, venture capital, specialized in the biotech sector, institutions, legal advisors, development experts, and service providers and equipment … Type: | 26 | 8 | 9 | 9 |
 | Genentech About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster … Type: | 63 | 7 | 1 | 18,036 |
 | LifeArc Transforming promising life science ideas into medical breakthroughs that change patients’ lives. LifeArc® is a medical research charity making life science life changing, transforming promising life science ideas into medical breakthroughs that change patients’ lives. We are self-funding and specialise in early-stage translation – advancing lab-based scientific discoveries to a point at which they can be developed into the next generation of diagnostics, treatments and cures. We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines. This includes Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) … Type: | 22 | 3 | 16 | 389 |
 | Institut G9+ L'Interclubs Numérique des Alumni des Grandes Écoles & Universités The G9 + Institute is a plural and apolitical think tank, promoting digital development in France. Federating 24 graduate communities of universities and colleges, and 50000 alumni, the G9 + Institute is one of the reference think tanks of digital for more than 22 years. Engaged in its historical mission of consultative source of proposals, the G9 + Institute wants to allow its members and friends to confront their ideas, deepen them and make them known. It brings an investigative, constructive and audacious light by publishing white papers and organizing about … Type: | 59 | 15 | 38 | 12 |
 | Frst We are the first believers The world produces a handful of legendary entrepreneurs a year. We are entrepreneurs too, and have designed from scratch the ideal partner for these unique people. A meaningful check at Day One, often even before the company actually exists. A responsive, reliable and knowledgeable counterpart with aligned interests. A long-term relationship we hope will last a decade. We are Frst. -- €200m+ AUM invested at day one in 50+ companies to date. Full portfolio on frst.vc Type: | 16 | 12 | 1 | 7 |
 | Synthace Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment. Biotech, Life Sciences, Software, Lab Automation, Bioprocessing, Engineering Biology, and Programming Type: | 19 | 1 | 14 | 74 |
 | Bicycle Therapeutics Precision-Guided Therapeutics Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC … Type: | 7 | 2 | 2 | 283 |
 | Eli Lilly and Company We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center … Type: | 104 | 25 | 48 | 45,821 |
 | EIT Health Together for healthy lives in Europe EIT Health promotes entrepreneurship and innovation in healthy living and active ageing, providing Europeans with new opportunities and resources. It enables citizens to lead healthier and more productive lives by delivering products, services and concepts that improve quality of life and contribute to the sustainability of healthcare across Europe. Health Care Administration, Health Consulting, Innovation in Healthy Living and Active Ageing, Sustainability of Healthcare, Acceleration, and Education Tags: H2020 Type: | 172 | 51 | 133 | 396 |
 | Eight Roads We back and partner with game-changing technology and healthcare companies in China, Europe, India, Japan and the US. Eight Roads Ventures is a global venture capital firm backed by Fidelity that helps entrepreneurs scale. We back and partner with game-changing technology and healthcare companies. With a presence in China, Europe, India and Japan, our global platform has 50+ years of venture investing experience, $11 Bn in AUM, over 300 portfolio companies and 60+ IPOs. Healthcare, Biosciences & Life Sciences, Consumer Technology, Internet & e-Commerce, FinTech & FinServ, Telecommunications, Food & Agriculture, Education and Skills Development, Enterprise Tech, Pharmaceuticals, Edu Tech, … Type: | 46 | 13 | 26 | 217 |
 | Casdin Capital, LLC Life Science Investments Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we … Type: | 6 | 2 | 0 | 46 |
 | HCVC We help fearless founders tackle hard problems with capital, resources and collaboration. HCVC is a venture capital firm that helps fearless founders tackle hard problems with capital, resources and collaboration. deeptech, venture capital, Seed, hardtech, pre-seed, and series A Type: | 69 | 12 | 46 | 24 |
 | Supernova Invest European deeptech VC, focused on high-growing start-ups and cutting-edge technologies Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and patient capital in the fields of Digital, Industrial Technologies, Healthcare and Cleantech to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Ynsect, Alice & Bob, Gleamer, Prophesee, Crowdsec, UnitySC or Unseenlabs. The Supernova team exited +25 companies through top IPO and M&A deals. The team is composed of +20 experienced investors with a unique ability to understand both the underlying technologies and the most … Type: | 77 | 30 | 51 | 34 |
 | Kima Ventures We fund ambitious, cohesive teams with stellar learning and execution curves. Investing in 2 to 3 startups per week, all over the world. Type: | 61 | 48 | 2 | 21 |
 | Chausson Partners We match smart money with great companies Chausson Finance is a leading fundraising advisory firm, providing deal making and equity story advice, as well as devoted support to inspiring founders. We helped shape +250 deals, and raise $1Bn. Our community of clients include leadership teams funded by Accel, Balderton, Alven and other top venture investors. Fundraising, Corporate Finance, Venture Capital, investment banking, equity rounds, M&A, Series A, Series B, and Equity Financing Type: | 19 | 3 | 16 | 16 |
 | KREAXI Financing partner for innovative start-ups KREAXI is one of the top French leaders in seed and venture capital, with €150m under management, 550 companies invested since last 30 years (of which 27 went public), 60 active portfolio companies, with a team of 16 persons based in Lyon and Paris. Type: | 51 | 21 | 30 | 9 |
 | Healthcare Data Institute Think Tank focused on transforming healthcare through the use of health data for the benefit of patients and citizens. The Healthcare Data Institute is a Think Tank, a collaborative structure, dedicated to the transformation of the healthcare system through the scientific and economic use of health data for the benefit of healthcare system stakeholders, patients, and citizens. healthcare, think tank, data mining, machine learning, Health Data, Artificial Intelligence, and Blockchain Type: | 72 | 7 | 62 | 8 |
 | TWB ACCELERATING DEVELOPMENT FROM BIOSCIENCES TO BIOPRODUCTION An expert in managing research and development projects (R&D), TWB* supports the industry to develop innovative and sustainable solutions for the benefit of the planet and people. TWB sets up and conducts R&D projects in collaboration with public laboratories and industrials, supports the development of start-ups by offering them accommodation on its premises in a state-of-the-art scientific and technological environment and encourages breakthrough innovation. By bringing together researchers, entrepreneurs, financiers, institutions and industry, TWB integrates and enhances all skills and expertise and creates synergies, while simplifying the contractual relationship. This unique model accelerates the … Type: | 37 | 8 | 30 | 74 |
 | Newfund This is where exceptional entrepreneurs get stronger Started in 2008 by and for founders, Newfund Capital is an early-stage VC firm active in France and in the USA. It has developed a strong culture centered around entrepreneurship and encourages initiatives to support the ambitions and the development of its portfolio companies. Newfund has $300 million in AUM subscribed mostly by entrepreneurs and family offices. Newfund's investment strategy is people-driven, focused on the constant search of entrepreneurs obsessed to realize their vision. We seek to understand entrepreneurs as individuals, appreciate their originality and play to their strengths. Greatness comes in all … Type: | 83 | 39 | 45 | 45 |
 | Voisin Consulting Life Sciences (VCLS) Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … Type: | 9 | 1 | 6 | 218 |
 | Karista Karista is a VC firm investing in game changers from scratch to success. Karista is an early-stage venture capital firm investing in ambitious entrepreneurs. For the past 20 years, we have been backing and guiding more than 100 companies from inception to success in Health, Digital, and Technology. Because we believe that investment is not only about money but mainly about people, we provide support to our founders and entrepreneurs very early-on. We come from different backgrounds and bring various skills to help nurturing our portfolio companies on many levels. We are currently deploying three European early stage funds: our … Type: | 14 | 6 | 6 | 21 |
 | L'AGEFI [Automatic translation follows] The leading information service for finance professionals in France. AGEFI is the leading information service for finance professionals in France. AGEFI relies on the 1st financial editorial team composed of 50 expert journalists in finance, allowing it to cover all sectors of finance: Asset Management, Private Equity, Institutional Investors, Cash & Risk, Heritage. Every day, our journalists analyze, decipher and delve deeper into the news and offer our readers unique information with very high added value (alerts, articles, analyses, in-depth reports, etc.) essential to their activity. AGEFI, as the facilitator of the communities that make up finance, … Type: | 246 | 99 | 207 | 175 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 7 | 2 | 6 | 36 |
 | AAVantgarde Bio Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases Type: | 1 | 1 | 0 | 34 |
 | BT Group We’re one of the world’s leading communications services companies. At BT Group, the solutions we sell are integral to modern life. Our purpose is as simple as it is ambitious: we connect for good. There are no limits to what people can do when they connect. And as technology changes our world, connections are becoming even more important to everyday life. Today, that’s truer than ever. The connections we make are helping solve the world’s biggest challenges such as the global pandemic, climate change and cyber security. Through the power of technology, we’re supporting customers to live, work and play … Type: | 78 | 31 | 19 | 78,321 |
 | Bruntwood 💡 Creating Thriving Cities: Workspace | Laboratories | Retail | Leisure Workspace | Laboratories | Retail | Leisure We own, let and manage outstanding buildings, workspace, innovation and science facilities. Our purpose: creating thriving cities. This purpose fuels our passion for supporting arts and culture, our deep community engagement and our ambitious plans for future growth. It ensures every investment and decision we make benefits our customers, our communities and our colleagues: because when our cities thrive, so do we. Our commitment to creating thriving cities has helped us to grow into a company with more than £1bn in assets … | 33 | 4 | 21 | 682 |
 | World Bio Markets & Bio Innovations Midwest Driving the bio-revolution together We connect markets and create relationships to drive the commercialisation of the bioeconomy. For years World Bio Markets (est. 2005) and World Bio Market Insights (est. 2015) have delivered market leading events and content for our clients and readers around the world. Now in 2024, we are delighted to have taken our event to the U.S. with Bio Innovations Midwest. World Bio Markets – 19-20 June 2025, The Hague: www.worldbiomarkets.com/ Bio Innovations Midwest – 15-16 September 2025, Omaha: bioinnovationsmidwest.com/ World Bio Market Insights – News & inspiration for the bioeconomy: worldbiomarketinsights.com/ We are committed to connecting … Type: | 39 | 3 | 36 | 16 |
 | ARCH Venture Partners We are contrarian. We are bold. We are imaginative risk takers. Early stage venture firm focused on life science discoveries to prevent, detect and cure disease. Type: | 2 | 2 | 0 | 55 |
 | Protera Smarter proteins for a sustainable future. By 2050, the world's population will surpass 10 billion people. To feed the current population and future generations we need to address global food challenges, today. How can we solve this problem without overwhelming the planet? And how can we deliver higher quality, more nutritious food for everyone? With Protera’s Natural IntelligenceTM technology, we believe the future is already here. Protera’s technology uses predictive algorithms that calculate millions of amino acid combinations and simulate protein patterns in a matter of seconds. Our technology is based in Deep Learning and allows us to shine a … Type: | 6 | 0 | 5 | 30 |
 | La villa numeris [Automatic translation follows] Think digital, make real La villa numeris is an independent think tank that promotes a European model of digital based on humans. Our mission: to enable decision-makers to understand and anticipate societal and economic transformations, to act accordingly, to raise awareness and mobilize to give meaning to organizations and succeed in their transformation. La villa numeris is an association under the 1901 Law financed by its members and by the sale of services. New Culture of Work, Working Differently, Connected Territories, Fake news, Digital citizen, Blockchain, AI, and Citizenship Type: | 44 | 4 | 27 | 10 |
 | Seamless Therapeutics Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. Type: | 1 | 1 | 0 | 28 |
 | NOVAMEAT Plant-Based Meat, Reinvented Based in the vibrant city of Barcelona, Novameat provides a range of authentic and sustainable plant-based meats. We simplify conscious choices, empowering people to effortlessly prioritise personal well-being and the future of our planet, without compromising on the gastronomic experience. Led by passionate innovators, we blend expertise in food science, biotechnology, and culinary arts to craft a unique texturising technology, creating nutritious food with an original taste and texture, and a satisfying bite. No soy, no gluten, no complex additives. Only protein-packed goodness. plant-based meat, food tech, cell-cultured meat, microextrusion, food, vegan, alternativeproteins, plantbased, altproteins, wholecuts, foodmanufacturing, … Type: | 6 | 1 | 4 | 35 |
 | Ecofi [Automatic translation follows] Assets for the future Management that influences tomorrow In 1972, our first Sicav was born, which has since become Epargne Ethique Flexible. 1st sharing fund in Europe created in 1983, launch of our solidarity fund in 2002, range of 100% SRI* funds in 2019, first French management company to adopt the status of mission-driven company in 2020... Ecofi works every day to combine financial performance and respect for Man and the Planet. This commitment has only grown over the years. Today, Ecofi is more than ever taking a long-term approach, combining control, involvement and sincerity to build, … Type: | 47 | 10 | 28 | 96 |
 | Cambridge Innovation Capital A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies. Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics. IP Commercialisation, Venture Capital, healthcare, … Type: | 35 | 7 | 23 | 38 |
 | Enterprise Investment Scheme Association (EISA) The UK's trade body for EIS and SEIS - the Enterprise Investment Scheme and Seed Enterprise Investment Scheme The UK's trade body for EIS and SEIS - the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. EISA is a highly effective not for profit organisation which exists to aid the provision of capital to UK small and medium-sized enterprises (SMEs) through the Enterprise Investment Scheme (EIS) and the Seed Enterprise Investment Scheme (SEIS). EISA works closely with HM Treasury, HM Revenue and Customs, Government Ministers, MPs and the FCA to enhance the EIS and promote the benefits of the scheme … Type: | 79 | 4 | 78 | 14 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 3 | 1 | 2 | 86 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 19 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … Type: | 4 | 1 | 2 | 141 |
 | DISCO Pharmaceuticals GmbH The surfaceome company. DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients. Type: | 1 | 1 | 0 | 24 |
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. BioEntrepreneur Club Building a start-up is no mean feat and the value of peer-to-peer support cannot be underestimated. So we’ve built a collaborative community exclusively for the founders and C-suite of early-stage life science companies in the UK, now with over 250 members. BioCapital Network Investment in all shapes and sizes is fundamental to growing the life science ecosystem. So we’ve established one of the largest investor communities, with over 300 members … Type: | 26 | 1 | 23 | 38 |
 | Mintz Built on excellence. Driven by change. Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto. Careers: www.mintz.com/careers Antitrust & Federal, Bankruptcy, Communications, Consumer Products, Corporate & Securities, Energy & Clean Tech, Environmental, Government, Health, Immigration, IP, International, Litigation, Private Client, Public Finance, Real … Type: | 8 | 2 | 3 | 1,372 |
 | TechCrunch Technology news and analysis with a focus on founders and startup teams TechCrunch, founded on June 11, 2005, is a news website dedicated to the tech scene. We provide breaking technology news, opinions, and analysis on tech companies from around the world. From publicly traded tech companies to emerging startups and venture capital funding rounds, TechCrunch is your number one guide for all things startups. blogging, startups, tech, technology, VC, venture capital, entrepreneurs, founders, and investors Type: | 403 | 254 | 63 | 400 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 238 |
 | BRAIN Biotech AG Developing a biobased future is our passion. Industrial biotechnology is our business. BRAIN Biotech AG is a leading European supplier of enzyme products, production strains and bioprocess solutions for more sustainable and efficient industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in the United Kingdom and production facilities in continental … Type: | 5 | 1 | 4 | 189 |
 | Sustainability Consult Credible sustainability & bioeconomy communications. Led by Conscious Business Leader Kathryn Sheridan since 2008. Sustainability Consult is dedicated to raising Credibility and Visibility for organisations worldwide. We are the leading bioeconomy communications and PR agency, based in Brussels, operating internationally. A trusted partner and recognised source for the media, Sustainability Consult has a proven track record in brand building, corporate communications and PR. We offer a full service of high-level consultancy services, from PR to communications and online strategy, through to issues management and crisis communications, as well as events, reports and media monitoring. We tweet @SustConsult. Follow us on … Type: | 14 | 5 | 10 | 3 |
 | GV (Google Ventures) Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward. GV supports innovative founders moving the world forward. We invest across the life sciences, consumer, enterprise, crypto, climate, and frontier technology sectors. With Alphabet as a sole limited partner, GV operates on long time horizons and deals in decades, not rounds. Our operating partners help startups at the earliest stages of company-building across design, equity, diversity & inclusion, talent, and engineering. We also help startups interface with Google, providing unique access to the world’s best technology and talent. Launched as Google Ventures in 2009, GV has … Type: | 67 | 16 | 13 | 328 |
 | Asabys Partners Investing in Life. Investing in Science. Investing in Future. Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in … Type: | 29 | 4 | 25 | 12 |
 | Wellington Management Trusted adviser to investors worldwide For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best investment ideas are found when a diverse workforce is encouraged to bring forward unique perspectives. Wellington Management is one of the world’s largest independent investment management firms, serving as a trusted adviser to over 2,400 clients in more than 60 countries. We manage more than US$1 trillion for pensions, endowments and foundations, insurers, family offices, fund sponsors, global wealth managers, and other clients. We offer comprehensive … Type: | 3 | 3 | 0 | 3,612 |
 | Fifty Years We back tech founders solving the world's biggest problems. Seed fund supporting entrepreneurs solving the world's biggest problems. There’s a sea change coming in business as big as the shift from desktop to the cloud, or from web to mobile. Fifty Years supports the entrepreneurs heralding in the new economic renaissance. Read our view here: http://techcrunch.com/2015/10/02/impact-is-the-new-mobile/ Type: | 41 | 9 | 26 | 21 |
 | HV Capital Backing those who dare HV Capital is one of the leading early-stage and growth investors in Europe. With nine fund generations in 23 years and €2.8 bn in managed assets, HV Capital is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition to international success stories like Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Enpal, Flixbus, Sennder, and Isar Aerospace are also part of the portfolio. HV Capital has invested in around 225 internet and technology companies, supporting startups with … Type: | 72 | 33 | 41 | 128 |
 | Calm/Storm Entrepreneurship is a continuous storm Calm/Storm is an exclusive founder network and boutique venture capital firm. We focus on talents, not industries. We believe in lifelong learning & personal growth, empowering entrepreneurs with unique access to successful founders. We are a fund built by founders for founders. Type: | 23 | 7 | 18 | 38 |
 | Otsuka Medical Devices Co., Ltd. Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage. Type: | 1 | 1 | 0 | 26 |
 | Marsh We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk and define more effective paths to the right outcome. We go beyond risk to rewards for our clients, our company, our colleagues, and the communities in which we serve. Marsh, a business of Marsh McLennan (NYSE: MMC), is the world’s top insurance broker and risk advisor. Marsh McLennan is a global leader in risk, strategy and people, … Type: | 47 | 14 | 18 | 12 |
 | Insempra We are a biology-powered company enabling businesses to make superior products with nature Insempra is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products. For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to drive the regenerative revolution to manufacture at scale in collaboration with nature. Led by a hand-picked team of biologists, technologists and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. … | 2 | 0 | 2 | 39 |
 | Phytolon Natural Food Colors Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast. food colors, natural ingredients, yeast, fermentation, sustainability, biotechnology, and foodtech Type: | 2 | 0 | 2 | 25 |
 | Endpoints News The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals Type: | 27 | 5 | 22 | 59 |
 | SOSV SOSV is a multi-stage, deep tech VC focused on planetary and human health SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on revolutionary deep technology that promises the betterment of humanity and the planet. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, Series A, and later rounds while providing founders with ongoing support and community. As … Type: | 102 | 28 | 65 | 493 |
 | Index Ventures Index helps the most ambitious entrepreneurs turn bold ideas into global businesses. Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their … | 27 | 12 | 10 | 110 |
 | Regeneration.VC Supercharging Consumer-Powered Climate Innovation Regeneration.VC is a global venture capital firm investing in Consumer ClimateTech innovation. Our investment strategy targets early-stage companies demonstrating asymmetric return potential by insetting environmentally aligned solutions within consumer value chains. Our mission is to realize abundance within planetary boundaries through regenerative consumer value chains. Have an innovation ready to supercharge? Submit here: https://form.fillout.com/t/dDYPidgNx4us Circular Economy, Sustainable Investing, Venture Capital, Consumer, Climate Tech, Regeneration, and Consumer ClimateTech Type: | 53 | 1 | 51 | 20 |
 |  harry Type: | 6 | 1 | 5 | 106 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 26 |
 | AMSilk GmbH | Biotech Materials 🌐 AMSilk is a frontrunner in advanced biomaterials made from spider silk-based proteins 🎯 Enabling true change AMSilk is a frontrunner in advanced biomaterials made from spider silk-based proteins. Using a patented technology platform, protected by a best-in-class patent portfolio, we are pushing boundaries in the field of bio-based materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers. biotech, biotech materials, biopolymers , zero-waste … Type: | 3 | 1 | 2 | 76 |
 | Virtonomy.io Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech Type: | 4 | 0 | 4 | 23 |
 | AngelNews News and comment from the world of angel investing AngelNews is a leading news service for the early-stage investment market including angel investors, venture capitalists, equity crowdfunding and entrepreneurs. Our aim is to encourage successful business by understanding the needs of our customers and offering bespoke services and packages to meet those needs. At present all of our publications and registration to our website is completely free of charge. Companies looking for funding also come to us to advertise their investment opportunities to our network of investors. With over 10,000 business angels and venture capitalists in our community, we have … Type: | 55 | 3 | 53 | 4 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 27 | 3 | 20 | 36 |
 | Arix Bioscience plc Investing in life changing science Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. Type: | 6 | 2 | 1 | 12 |
 | Portugal Digital Moving Forward Moving With a Purpose Portugal Digital is the country's transformation engine. Its purpose is to accelerate Portugal, without leaving anyone behind, and to highlight this mission in the world. How? Through the digital empowerment of people, the digital transformation of businesses and the digitalization of the Public Administration. Type: | 13 | 4 | 10 | 1 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 1 | 1 | 306 |
 | SynBioBeta We help you connect with, better understand, and do business with those using biology to make the planet a better place. SynBioBeta is the premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet. We provide our community members with personal and professional development support, as well as valuable opportunities for networking, partnership, collaboration, and education. Every year we host The Global Synthetic Biology Conference which showcases the cutting-edge developments in biology that are transforming how we fuel, heal, and feed the world. In addition, we … Type: | 56 | 6 | 51 | 28 |
 | deepc Increasing diagnostic quality through the collaboration of medical professionals and AI. deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai Digital Health, Deep Learning, Machine … Type: | 1 | 1 | 1 | 70 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 27 | 4 | 20 | 3,850 |
 | Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 20 | 8 | 13 | 112 |
 | ClimateHack ClimateHack is where impact-driven Founders and Funders come to meet, learn and build together. Join us at a ClimateHack Meetup to connect with your local community. Subscribe to ClimateHack weekly to stay ahead of the curve on the latest funding, partnerships and news in ClimateTech. Type: | 30 | 16 | 21 | 29 |
 | Italian Tech Alliance [Automatic translation follows] Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - startups and innovative SMEs. The association's goal is to promote the development of the technology and innovation ecosystem in Italy, working closely with the institutions. The contents of Italian Tech Alliance spread news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. Currently sitting on the Board of Directors: - Alessio … Type: | 12 | 5 | 6 | 16 |
Incubators & VCs